# Medirom Healthcare Technologies Inc.: financial statements, quarterly

MRM · Nasdaq · CIK 1819704 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mrm.md) · [Financials](/companies/mrm/financials.md) · [Filings](/companies/mrm/filings.md) · [Insiders](/companies/mrm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mrm/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2018-12-31) | period not labelled (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | [4.6](/filings/0001558370-23-010611.md) | [0.8](/filings/0001558370-24-009293.md) | [2.1](/filings/0001558370-25-005850.md) |
| Current assets | $m | not reported | [1,379](/filings/0001558370-21-007318.md) | [2,087](/filings/0001558370-22-017729.md) | [1,382](/filings/0001558370-23-010611.md) | [2,363](/filings/0001558370-24-009293.md) | [1,759](/filings/0001558370-25-005850.md) | [2,706](/filings/0001558370-25-005850.md) |
| Total assets | $m | not reported | [4,757](/filings/0001558370-22-017729.md) | [5,713](/filings/0001558370-23-010611.md) | [5,753](/filings/0001558370-24-009293.md) | [6,747](/filings/0001558370-25-005850.md) | [6,849](/filings/0001558370-25-005850.md) | [8,091](/filings/0001558370-25-005850.md) |
| Current liabilities | $m | not reported | [2,263](/filings/0001558370-21-007318.md) | [2,653](/filings/0001558370-22-017729.md) | [3,196](/filings/0001558370-23-010611.md) | [3,642](/filings/0001558370-24-009293.md) | [3,561](/filings/0001558370-25-005850.md) | [4,181](/filings/0001558370-25-005850.md) |
| Total liabilities | $m | not reported | not reported | [5,222](/filings/0001558370-22-017729.md) | [5,961](/filings/0001558370-23-010611.md) | [6,807](/filings/0001558370-24-009293.md) | [6,633](/filings/0001558370-25-005850.md) | [6,903](/filings/0001558370-25-005850.md) |
| Long-term debt | $m | not reported | [151](/filings/0001558370-21-007318.md) | [668](/filings/0001558370-22-017729.md) | [747](/filings/0001558370-23-010611.md) | [1,150](/filings/0001558370-24-009293.md) | [1,051](/filings/0001558370-25-005850.md) | [764](/filings/0001558370-25-005850.md) |
| Current portion of debt | $m | not reported | [192](/filings/0001558370-21-007318.md) | [242](/filings/0001558370-22-017729.md) | [162](/filings/0001558370-23-010611.md) | [99.2](/filings/0001558370-24-009293.md) | [100](/filings/0001558370-25-005850.md) | [621](/filings/0001558370-25-005850.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | [400](/filings/0001558370-25-005850.md) | [492](/filings/0001558370-25-005850.md) |
| Shareholders' equity | $m | [(118)](/filings/0001558370-22-017729.md) | [600](/filings/0001558370-23-010611.md) | [491](/filings/0001558370-23-010611.md) | [(208)](/filings/0001558370-23-010611.md) | [(59.4)](/filings/0001558370-24-009293.md) | [211](/filings/0001558370-25-005850.md) | [933](/filings/0001558370-25-005850.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

Shares outstanding: 7,901,950 at 2024-12-31, from the cover of the [20-F filed 2025-04-29](/filings/0001558370-25-005850.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.